This thesis reports for the first time the detection of porcine circovirus virus (PCV) in the Australian pig herd. PCV DNA was detected in the tissues of pigs from several Australian states using a multiplex polymerase chain reaction (PCR) assay, the primers for which were based on the sequence of PCV1 and PCV2 strains detected in North America and Europe. PCV type 1 or 2 was detected in 80 of 367 (21.7%) pigs tested. In the 80 positives, both PCV1 and PCV2 were detected in 14 samples. Virus was detected in pigs from all states from which samples were obtained: Western Australia, South Australia, New South Wales and Queensland. The complete genomes of 13 strains of Australian PCV were sequenced. Analysis of the data indicated there was extremely high homology between the Australian strains of PCV1 and PCV2 and previously published sequences of PCV1 and PCV2 strains from North America and Europe.There were no consistent differences between the genome of the Australian strains and strains in North America and Europe. The widespread occurrence of PCV in the tissues of pigs was confirmed by a small scale serological study of the Western Australian pig herd using an immunofluorescence assay, which did not discriminate antibody to PCV1 and PCV2. This assay detected PCV antibody in 11 of 14 pig herds in Western Australia, with a prevalence rate in positive herds varying from 25 to 47%, but it was unable to differentiate antibody to PCV1 and PCV2. A PCV2-specific recombinant viral capsid protein was produced in insect cells with a baculovirus expression system and this was used to develop a PCV2-specific ELISA and a Western immunoblotting assay. These assays were applied to samples from a national pig serum bank and detected PCV2 antibody in 33% of 3933 serum samples. The highest seroprevalence to the recombinant PCV2 capsid antigen was detected in the samples from Victoria where there was a 51.3% seroprevalence rate, and the lowest in Western Australia where there was an 11.4% seroprevalence rate. An in situ hybridisation (ISH) technique was developed for the detection of PCV in tissues of infected pigs and infected cell cultures. A monoclonal antibody specific for the capsid protein of PCV2 was also produced and has application for the development of immunocytochemical procedures for the detection of PCV2 in tissues and cell cultures. The high prevalence of PCV in the Australian pig herd and the absence of reports of PMWS suggested that the Australian strains of PMWS detected may have been of low virulence. To examine the pathogenicity of Australian strains, two animal experiments were conducted where the type species of PCV1 present in persistently-infected PK15 pig kidney cells and an Australian PCV2 strain were cultured in vitro in cell cultures and inoculated into weaner pigs. As expected, the PCV1 replicated well in pigs but did not result in the induction of clinical signs or lesions in the inoculated pigs. The inoculation into weaner pigs of cell culture replicated PCV2 with an apparent virus titre of 103 virus particles/mL resulted in infection of only some of the inoculated pigs and it was concluded that the PCV2 inoculum contained insufficient virus to infect all pigs into which it was inoculated. The PCV2 did not induce any disease syndrome and could not be visualised in tissue sections of infected pigs using immunohistochemical techniques. In conclusion, techniques were developed for the detection of PCV in the Australian pig herd. PCV of both genetic types were detected at prevalence rates similar to those reported in other countries where PMWS has occurred, and the widespread occurrence of PCV was confirmed by serological assays. The PCV strains present were genetically indistinguishable from those present in North America and Europe. The reason for the absence of PMWS in Australia is most likely not due to differences in the characteristics of the PCV strains present.

A presente tese versa sobre estudos realizados visando a identificação de novos agentes virais em frangos comerciais. No primeiro capítulo, a identificação do girovírus aviário tipo 2 (AGV2) é reportada. Um genoma viral de 2383 nt foi amplificado a partir soros de frangos comerciais por amplificação randômica de DNA. A análise da sequência do produto amplificado, revelou que cerca de 40% das sequencias de nucleotídeos apresentavam similaridade com o genoma do vírus da anemia infecciosa das galinhas (CAV). Dado o baixo grau de identidade com o CAV, o genoma identificado justificou a proposição de um novo tipo de vírus, dentro do gênero gyrovírus foi denominado “girovírus aviário tipo 2” (AGV2). O genoma do AGV2 tem organização semelhante a do CAV, com percentagens de similitude de aminoácidos nas regiões codificantes, correspondentes às proteínas virais VP1, VP2 e VP3 do CAV de 38,8%, 40,3% e 32,2%, respectivamente. A fim de analisar a amplitude da disseminação deste agente, foi realizado um estudo para identificar a ocorrência do AGV2 em granjas de frangos de outras regiões. Para atingir esse objetivo, uma PCR específica ao AGV2 foi desenvolvida para amplificar o DNA viral extraído de bulbos de penas da asa e órgãos de frangos. Essa técnica permitiu a detecção do AGV2 em aves de outros locais na Região Sul do Brasil. O DNA viral foi detectado em 90,7% (98/108) das amostras coletadas no estado do Rio Grande do Sul e 60,4% (29/48) das amostras do estado de Santa Catarina. Os mesmo primers da PCR foram adaptados para examinar tecidos de cérebro de galinhas da Holanda. Nessas amostras o DNA do AGV2 foi detectado em nove das 21 (42,9%) amostras de tecidos cerebrais em aves com lesões hemorrágicas. Essas descobertas fornecem evidências de que infecções de AGV2 são generalizadas e não se restringem a Região Sul do Brasil. Além disso, esses estudos permitiram a identificação de variantes do DNA genômico do AGV2. Análises filogenéticas demostraram que os genomas examinados poderiam ser divididos em três grupos, com base em diferenças nos genes das ORFs das proteínas VP2 e VP3. Em conclusão, a presente tese abrange estudos da identificação de um vírus aviário, até então desconhecido, denominado girovírus aviário tipo 2, que encontra-se amplamente distribuído. A associação deste agente com enfermidades em aves será tema de estudos que estão sendo realizados. / This thesis concerns studies carried out in search for new viral agents in commercial poultry flocks. In the first chapter, the identification of the genome of avian gyrovirus type 2 (AGV2), a new Gyrovirus, is reported. The viral genome the 2383-nucleotide sequence was amplified from sera of commercial broilers by random DNA amplification. Sequence analysis of the amplified product showed that the putative viral sequence had about 40% nucleotide similarity with the genome of its closest relative, chicken anemia virus (CAV). Such low degree of nucleotide similarity justified its classification as a new virus type within the genus, to which the name avian gyrovirus type 2. The amino acid similarity between the predicted viral proteins VP1, VP2 and VP3 of AGV2 and those of CAV was 38.8%, 40.3%, and 32.2%, respectively. In order to examine the amplitude of dissemination of this agent, it became necessary to carry out a search for AGV2 genomes in poultry flocks from other regions. To achieve such objective, an AGV2-specific PCR was designed to amplify viral DNA from nuclei acid extracted from poultry feather shafts. This allowed detection of AGV2 genomes in flocks from other locations in Southern Brazil. Viral DNA was detected in 98/108 (90.7%) of samples collected in the state of Rio Grande do Sul and 29/48 (60.4%) of the samples collected in the state of Santa Catarina. The same PCR primers were adapted to examine brain tissues of chickens from the Netherlands. In such samples, AGV2 DNA was detected in nine out of 21 (42.9%) brain tissue samples from birds with haemorragic lesions. These findings provided evidence that AGV2 infections are widespread and are not restricted to Southern Brazil. In addition, these studies allowed the identification of genomic variants of AGV2. Phylogenetic analyses demonstrated that such genomes could be divided into three clusters. In conclusion, this thesis encompasses studies on the identification of a previously unreported virus, named avian gyrovirus 2, which was later shown to be widely distributed. The relationship between this agent and disease in poultry will be subject of further studies which are being performed in continuation to this work.

A presente tese versa sobre estudos realizados visando a identificação de novos agentes virais em frangos comerciais. No primeiro capítulo, a identificação do girovírus aviário tipo 2 (AGV2) é reportada. Um genoma viral de 2383 nt foi amplificado a partir soros de frangos comerciais por amplificação randômica de DNA. A análise da sequência do produto amplificado, revelou que cerca de 40% das sequencias de nucleotídeos apresentavam similaridade com o genoma do vírus da anemia infecciosa das galinhas (CAV). Dado o baixo grau de identidade com o CAV, o genoma identificado justificou a proposição de um novo tipo de vírus, dentro do gênero gyrovírus foi denominado “girovírus aviário tipo 2” (AGV2). O genoma do AGV2 tem organização semelhante a do CAV, com percentagens de similitude de aminoácidos nas regiões codificantes, correspondentes às proteínas virais VP1, VP2 e VP3 do CAV de 38,8%, 40,3% e 32,2%, respectivamente. A fim de analisar a amplitude da disseminação deste agente, foi realizado um estudo para identificar a ocorrência do AGV2 em granjas de frangos de outras regiões. Para atingir esse objetivo, uma PCR específica ao AGV2 foi desenvolvida para amplificar o DNA viral extraído de bulbos de penas da asa e órgãos de frangos. Essa técnica permitiu a detecção do AGV2 em aves de outros locais na Região Sul do Brasil. O DNA viral foi detectado em 90,7% (98/108) das amostras coletadas no estado do Rio Grande do Sul e 60,4% (29/48) das amostras do estado de Santa Catarina. Os mesmo primers da PCR foram adaptados para examinar tecidos de cérebro de galinhas da Holanda. Nessas amostras o DNA do AGV2 foi detectado em nove das 21 (42,9%) amostras de tecidos cerebrais em aves com lesões hemorrágicas. Essas descobertas fornecem evidências de que infecções de AGV2 são generalizadas e não se restringem a Região Sul do Brasil. Além disso, esses estudos permitiram a identificação de variantes do DNA genômico do AGV2. Análises filogenéticas demostraram que os genomas examinados poderiam ser divididos em três grupos, com base em diferenças nos genes das ORFs das proteínas VP2 e VP3. Em conclusão, a presente tese abrange estudos da identificação de um vírus aviário, até então desconhecido, denominado girovírus aviário tipo 2, que encontra-se amplamente distribuído. A associação deste agente com enfermidades em aves será tema de estudos que estão sendo realizados. / This thesis concerns studies carried out in search for new viral agents in commercial poultry flocks. In the first chapter, the identification of the genome of avian gyrovirus type 2 (AGV2), a new Gyrovirus, is reported. The viral genome the 2383-nucleotide sequence was amplified from sera of commercial broilers by random DNA amplification. Sequence analysis of the amplified product showed that the putative viral sequence had about 40% nucleotide similarity with the genome of its closest relative, chicken anemia virus (CAV). Such low degree of nucleotide similarity justified its classification as a new virus type within the genus, to which the name avian gyrovirus type 2. The amino acid similarity between the predicted viral proteins VP1, VP2 and VP3 of AGV2 and those of CAV was 38.8%, 40.3%, and 32.2%, respectively. In order to examine the amplitude of dissemination of this agent, it became necessary to carry out a search for AGV2 genomes in poultry flocks from other regions. To achieve such objective, an AGV2-specific PCR was designed to amplify viral DNA from nuclei acid extracted from poultry feather shafts. This allowed detection of AGV2 genomes in flocks from other locations in Southern Brazil. Viral DNA was detected in 98/108 (90.7%) of samples collected in the state of Rio Grande do Sul and 29/48 (60.4%) of the samples collected in the state of Santa Catarina. The same PCR primers were adapted to examine brain tissues of chickens from the Netherlands. In such samples, AGV2 DNA was detected in nine out of 21 (42.9%) brain tissue samples from birds with haemorragic lesions. These findings provided evidence that AGV2 infections are widespread and are not restricted to Southern Brazil. In addition, these studies allowed the identification of genomic variants of AGV2. Phylogenetic analyses demonstrated that such genomes could be divided into three clusters. In conclusion, this thesis encompasses studies on the identification of a previously unreported virus, named avian gyrovirus 2, which was later shown to be widely distributed. The relationship between this agent and disease in poultry will be subject of further studies which are being performed in continuation to this work.

A presente tese versa sobre estudos realizados visando a identificação de novos agentes virais em frangos comerciais. No primeiro capítulo, a identificação do girovírus aviário tipo 2 (AGV2) é reportada. Um genoma viral de 2383 nt foi amplificado a partir soros de frangos comerciais por amplificação randômica de DNA. A análise da sequência do produto amplificado, revelou que cerca de 40% das sequencias de nucleotídeos apresentavam similaridade com o genoma do vírus da anemia infecciosa das galinhas (CAV). Dado o baixo grau de identidade com o CAV, o genoma identificado justificou a proposição de um novo tipo de vírus, dentro do gênero gyrovírus foi denominado “girovírus aviário tipo 2” (AGV2). O genoma do AGV2 tem organização semelhante a do CAV, com percentagens de similitude de aminoácidos nas regiões codificantes, correspondentes às proteínas virais VP1, VP2 e VP3 do CAV de 38,8%, 40,3% e 32,2%, respectivamente. A fim de analisar a amplitude da disseminação deste agente, foi realizado um estudo para identificar a ocorrência do AGV2 em granjas de frangos de outras regiões. Para atingir esse objetivo, uma PCR específica ao AGV2 foi desenvolvida para amplificar o DNA viral extraído de bulbos de penas da asa e órgãos de frangos. Essa técnica permitiu a detecção do AGV2 em aves de outros locais na Região Sul do Brasil. O DNA viral foi detectado em 90,7% (98/108) das amostras coletadas no estado do Rio Grande do Sul e 60,4% (29/48) das amostras do estado de Santa Catarina. Os mesmo primers da PCR foram adaptados para examinar tecidos de cérebro de galinhas da Holanda. Nessas amostras o DNA do AGV2 foi detectado em nove das 21 (42,9%) amostras de tecidos cerebrais em aves com lesões hemorrágicas. Essas descobertas fornecem evidências de que infecções de AGV2 são generalizadas e não se restringem a Região Sul do Brasil. Além disso, esses estudos permitiram a identificação de variantes do DNA genômico do AGV2. Análises filogenéticas demostraram que os genomas examinados poderiam ser divididos em três grupos, com base em diferenças nos genes das ORFs das proteínas VP2 e VP3. Em conclusão, a presente tese abrange estudos da identificação de um vírus aviário, até então desconhecido, denominado girovírus aviário tipo 2, que encontra-se amplamente distribuído. A associação deste agente com enfermidades em aves será tema de estudos que estão sendo realizados. / This thesis concerns studies carried out in search for new viral agents in commercial poultry flocks. In the first chapter, the identification of the genome of avian gyrovirus type 2 (AGV2), a new Gyrovirus, is reported. The viral genome the 2383-nucleotide sequence was amplified from sera of commercial broilers by random DNA amplification. Sequence analysis of the amplified product showed that the putative viral sequence had about 40% nucleotide similarity with the genome of its closest relative, chicken anemia virus (CAV). Such low degree of nucleotide similarity justified its classification as a new virus type within the genus, to which the name avian gyrovirus type 2. The amino acid similarity between the predicted viral proteins VP1, VP2 and VP3 of AGV2 and those of CAV was 38.8%, 40.3%, and 32.2%, respectively. In order to examine the amplitude of dissemination of this agent, it became necessary to carry out a search for AGV2 genomes in poultry flocks from other regions. To achieve such objective, an AGV2-specific PCR was designed to amplify viral DNA from nuclei acid extracted from poultry feather shafts. This allowed detection of AGV2 genomes in flocks from other locations in Southern Brazil. Viral DNA was detected in 98/108 (90.7%) of samples collected in the state of Rio Grande do Sul and 29/48 (60.4%) of the samples collected in the state of Santa Catarina. The same PCR primers were adapted to examine brain tissues of chickens from the Netherlands. In such samples, AGV2 DNA was detected in nine out of 21 (42.9%) brain tissue samples from birds with haemorragic lesions. These findings provided evidence that AGV2 infections are widespread and are not restricted to Southern Brazil. In addition, these studies allowed the identification of genomic variants of AGV2. Phylogenetic analyses demonstrated that such genomes could be divided into three clusters. In conclusion, this thesis encompasses studies on the identification of a previously unreported virus, named avian gyrovirus 2, which was later shown to be widely distributed. The relationship between this agent and disease in poultry will be subject of further studies which are being performed in continuation to this work.

Tesis presentada a la Universidad de Chile para optar al grado de Magíster en Bioquímica área de Especialización en Bioquímica Clínica / Cyclovirus (CyCV) es un agente infeccioso, recientemente descubierto, con un pequeño material genético de DNA circular de hebra simple que codifica para una proteína asociada a la replicación (Rep) y otra a la capside viral (Cap). Infecta diversos organismos eucariontes, incluyendo humanos, donde se han descrito variantes genéticas con prevalencia de hasta 15,7% en niños con parálisis flácida aguda. El genoma del CyCV se ha detectado en distintas muestras biológicas de población enferma y asintomática, desconociéndose su rol patogénico. En Chile, sólo se ha estudiado en aspirado nasofaríngeo de niños con enfermedad respiratoria aguda baja (ERA), detectándose en el 3,3% y describiéndose una nueva cepa viral denominada CyCV-ChileNPA. El objetivo de esta tesis fue detectar y genotipificar variantes de la cepa chilena de cyclovirus en niños y adultos, con y sin enfermedad respiratoria. En 101 menores de un año hospitalizados por ERA, 105 mayores de 18 años hospitalizados por neumonía adquirida en la comunidad (NAC), 104 niños y 104 adultos sin sintomatología respiratoria, por al menos un mes previo al enrolamiento, cuyas muestras respiratorias se obtuvieron entre 2012-2016 en Santiago, se amplificó un fragmento del gen Rep de cyclovirus mediante reacción en cadena de la polimerasa en tiempo real con el reactivo Kapa PROBE® a partir de extractos de ácidos nucleicos totales obtenidos con el kit MasterPure (Epicenter®). Los amplificados se purificaron con el kit GEL/PCR Purification (FAVORGEN®) y se secuenciaron en Macrogen® (Corea). Las muestras secuenciadas se alinearon con BLAST y con el programa BioEdit® generándose una secuencia consenso. Se detectó CyCV en un 54,3% (57/105) de los adultos NAC; 17,3% (18/104) en adultos sin sintomatología respiratoria; 14,9% en niños con ERA (15/101) y en 48,1% (50/104) de niños sin ERA. Los 79 (84%) amplificados de 149pb tuvieron un 99% de identidad con la secuencia nucleotídica correspondiente de la proteína Rep de CyCV-ChileNPA. Por primera vez se detecta CyCV en muestra respiratoria de adultos, con una frecuencia significativamente mayor en pacientes con NAC que en adultos sin enfermedad respiratoria, lo que sugeriría la presencia de este virus en adultos con enfermedad respiratoria. Por otra parte, la detección en niños fue mayor a la publicada y similar entre casos con y sin ERA / Cyclovirus (CyCV) is a recently discovered infectious agent, with little DNA simple strand genetic material that codifies for a protein associated to the replication (Rep) and to the viral capside (Cap). It infects different eukaryotic organisms, including humans, where it has been described genetic variants with up to 15,7% prevalence in children with acute flaccid paralysis. CyCV genome has been detected in different biological samples in illness and asymptomatic population, with an unknown pathogenic role. In Chile, it has been studied in nasopharyngeal aspirate only in children with lower respiratory tract infections, detected in 3,3% and being described a new viral strain named CyCV-ChileNPA. The objective of this thesis was to detect and genotype the Chilean cyclovirus strain variants in children and adults, with and without respiratory infections. In 101 children under 1 year hospitalized by acute respiratory infection (ARI), 105 adults over 18 years hospitalized by community-acquired pneumonia (CAP), 104 children and 104 adults without respiratory symptomatology, for at least 1 month prior to enrollment, whose samples were obtained between 2012 and 2016 in Santiago, a fragment of the Rep gene of cyclovirus was amplified through a chain reaction of the polymerase in real time using Kapa PROBE® reagent from total nucleic acid extracts obtained with MasterPure kit (Epicenter®). The amplifiers were purified with the GEL/PCR Purification kit (FAVORGEN®) and sequenced in Macrogen® (Corea). The sequenced samples were aligned with BLAST and using BioEdit® program, generating a consensus sequence. CyCV was detected in 54,3% of adults with CAP; 17,3% (18/104) in adults without respiratory symptomatology; 14,9% in children with ARI (15/101) and 48,1% (50/104) children without ARI. All of the 79 amplified (84%) of 149pb had 99% of identity with nucleotide sequence corresponding to CyCV-ChileNPA Rep protein. It is the first time that CyCV is detected in respiratory samples in adults, with a significantly higher frequency in patients with CAP than in adults without respiratory disease, and it would suggest the presence of this virus in adults with respiratory disease. On the other hand, the detection in children was higher than the previously published and similar to cases with and without ARI

Diss. (sammanfattning) Uppsala : Sveriges lantbruksuniv., 2008. / Härtill 5 uppsatser.

A suinocultura brasileira representa uma importante atividade econômica para o país, o qual ocupa lugar de destaque na produção e exportação de carne suína no mundo. O destaque do país na produção de suínos, deve-se a melhorias na sanidade, manejo, produção integrada e, principalmente, no aprimoramento gerencial dos produtores. O primeiro artigo consistiu em determinar a frequência e a distribuição das doenças infecciosas (DI) diagnosticadas através de exame de necropsia e histopatologia em suínos nas fases de crescimento e terminação ao longo de 12 anos (2005-2016) no sul do Brasil. Foram avaliados 1906 laudos anatomopatológicos de suínos nas fases de crescimento/terminação, dos quais as DI corresponderam a 75,6% (1441 casos) do total. As infecções por circovírus suíno tipo 2 (PCV2) foram as mais frequentes, contabilizando 51,3% (739/1441) dos casos, seguidas por DI que afetam o sistema respiratório (30,1% dos casos). Dentre essas, destacam-se a influenza suína A (15,1%; 218/1441) e pneumonias bacterianas (15%; 216/1441). O diagnóstico de influenza exibiu uma frequência elevada entre os anos de 2010 a 2013, totalizando 43,1% (167/387) dos casos. Após este período, ambas DI respiratórias exibiram caráter endêmico. As DI que afetam o sistema digestório totalizaram 10,5% (151/1441) dos diagnósticos, com as seguintes condições: enterocolite por Salmonella spp. (43,7%; 66/151), enteropatia proliferativa por Lawsonia spp. (41,7%; 63/151) e colite por Brachyspira spp. (14,6%; 22/151). Além dessas, as polisserosites e meningites bacterianas representaram 5,8% (84/1441) e 2,3% (33/1441) dos casos diagnosticados, respectivamente. O segundo artigo descreve três surtos de doença por circovírus suíno tipo-2 (PCVD) com lesões envolvendo musculatura esquelética. Em um curso clínico de 7 a 10 dias, 92 suínos apresentaram apatia, emagrecimento e diarreia. Ainda, cerca de 30 dos suínos afetados, apresentavam dificuldade de locomoção, fraqueza muscular, paresia de membros pélvicos e decúbito permanente. Quatro suínos exibiram palidez em músculos esqueléticos dos membros pélvicos, torácicos e dorso-lombares. As lesões microscópicas observadas consistiam de miosite necrótica granulomatosa, predominantemente, em membros pélvicos e torácicos, e em menor intensidade nos músculos dorso-lombares. No exame imuno-histoquímico para PCV2 observou-se marcação multifocal acentuada, predominantemente, no citoplasma e núcleos de macrófagos, linfócitos e células gigantes multinucleadas, além de marcação discreta no citoplasma no citoplasma de fibras necróticas da musculatura esquelética. As amostras de músculo esquelético foram positivas na reação em cadeia de polimerase para PCV2 e a ampliação exibiu 99% de identidade com sequências pertencentes ao genótipo PCV2b. / Brazilian pig farms represent an important economic activity for the country, which occupies a prominent place in the production and export of pork in the world. The country's prominence in pork production is due to improvements in sanitation, management, integrated production and, mainly, in the managerial improvement of the producers. The first study aimed to determine the frequency and distribution of infectious diseases (ID) diagnosed through necropsy and histopathology examination in growing-finishing swine along 12 years (2005-2016) in Southern Brazil. A total of 1906 anatomopathological exams performed in growing-finishing swine were evaluated, of which ID accounted for 75.6% (1441 cases) of the total. Porcine circovirus type 2 (PCV2) infections were the most frequent, accounting for 51.3% of the cases (739/1441), followed by respiratory system ID (30.1% of the cases). Among these, the main conditions were swine influenza (15.1%; 218/1441) and bacterial pneumonia (15%; 216/1441). Influenza diagnosis had a higher frequency between 2010 and 2013, accounting for 43,1% (167/387) of the cases. After this period, both respiratory ID had an endemic occurrence. Digestive system ID accounted for 10.5% (151/1441) of the diagnosis, with the main conditions diagnosed: Salmonella spp. enterocolitis (43.7%; 66/151), Lawsonia spp. proliferative enteropathy (41.7%; 63/151) and Brachyspira spp. colitis (14.6%; 22/151). Besides these, polyserositis and bacterial meningitis represented, respectively, 5.8% (84/1441) and 2.3% (33/1441) of the cases diagnosed. The second study describes three outbreak of porcine circovirus disease (PCVD) with the involvement of skeletal muscle. In a clinical course of 7 to 10 days, 92 pigs had apathy, weight loss and diarrhea. Approximately 30 of these 92 pigs had stiff gait, muscle weakness, hind limb paresis, and recumbency. 4 pigs necropsied presented pale discoloration from hind and thoracic limbs, as well from dorsal lumbar skeletal muscles. The microscopical lesions consisted of granulomatous necrotizing myositis mainly of hind and thoracic limbs, and mildly from dorsal lumbar muscles. Immunohistochemistry exam for PCV2 revealed marked multifocal intracytoplasmic and intranuclear staining predominantly in macrophages, lymphocytes and multinucleated giant cells, with a lower amount in the cytoplasm of necrotic fibers of the skeletal muscle. Affected muscle samples were polymerase chain reaction– positive for PCV2 and the amplicon exhibited 99% identity with sequences belonging to the PCV2b genotype.